Susumu S Kobayashi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

The Journal of experimental medicine

Communications biology

Cell death & disease

Molecular cancer research : MCR

National Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Center Apr 01 2018

Japan

Cheif, Division of Translational Genomics :: Exploratory Oncology Research & Clinical Trial Center

Publications

Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Motohiro Izumi, Masanori Fujii, Ikei S Kobayashi, Vivian Ho, Yukie Kashima, Hibiki Udagawa, Daniel B Costa, Susumu S Kobayashi
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. Cell death & disease 15 (8) (2024)
Hollis Viray, Andrew J Piper-Vallillo, Page Widick, Emmeline Academia, Meghan Shea, Deepa Rangachari, Paul A VanderLaan, Susumu S Kobayashi, Daniel B Costa
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice. Cancers 16 (6) (2024)
Motohiro Izumi, Masanori Fujii, Ikei S Kobayashi, Vivian Ho, Yukie Kashima, Hibiki Udagawa, Daniel B Costa, Susumu S Kobayashi
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. Cell death & disease 15 (8) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Hollis Viray, Andrew J Piper-Vallillo, Page Widick, Emmeline Academia, Meghan Shea, Deepa Rangachari, Paul A VanderLaan, Susumu S Kobayashi, Daniel B Costa
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice. Cancers 16 (6) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yosuke Kagawa, Yukari Sagae, Biao Ma, Yuta Isaka, Yoko Sasakura, Shogo Kumagai, Yuta Sakae, Kosuke Tanaka, Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Yasushi Okuno, Koichi Goto, Susumu S Kobayashi
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion. Communications biology 7 (1) (2024)
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yosuke Kagawa, Yukari Sagae, Biao Ma, Yuta Isaka, Yoko Sasakura, Shogo Kumagai, Yuta Sakae, Kosuke Tanaka, Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Yasushi Okuno, Koichi Goto, Susumu S Kobayashi
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion. Communications biology 7 (1) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yosuke Kagawa, Yukari Sagae, Biao Ma, Yuta Isaka, Yoko Sasakura, Shogo Kumagai, Yuta Sakae, Kosuke Tanaka, Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Yasushi Okuno, Koichi Goto, Susumu S Kobayashi
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion. Communications biology 7 (1) (2024)
Motohiro Izumi, Masanori Fujii, Ikei S Kobayashi, Vivian Ho, Yukie Kashima, Hibiki Udagawa, Daniel B Costa, Susumu S Kobayashi
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. Cell death & disease 15 (8) (2024)
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yosuke Kagawa, Yukari Sagae, Biao Ma, Yuta Isaka, Yoko Sasakura, Shogo Kumagai, Yuta Sakae, Kosuke Tanaka, Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Yasushi Okuno, Koichi Goto, Susumu S Kobayashi
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion. Communications biology 7 (1) (2024)
Sho Tabata, Shigeki Umemura, Miyu Narita, Hibiki Udagawa, Takamasa Ishikawa, Masahiro Tsuboi, Koichi Goto, Genichiro Ishii, Katsuya Tsuchihara, Atsushi Ochiai, Susumu S Kobayashi, Tomoyoshi Soga, Hideki Makinoshima
Metabolic hallmarks for purine nucleotide biosynthesis in small-cell lung carcinoma. Molecular cancer research : MCR (2023)
Fareesa Aftab, Alice Rodriguez-Fuguet, Luis Silva, Ikei S Kobayashi, Jiao Sun, Katerina Politi, Elena Levantini, Wei Zhang, Susumu S Kobayashi, Wen Cai Zhang
An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1. British journal of cancer (2023)
Daisuke Shibahara, Naoki Akanuma, Ikei S Kobayashi, Eunyoung Heo, Mariko Ando, Masanori Fujii, Feng Jiang, P Nicholas Prin, Gilbert Pan, Kwok-Kin Wong, Daniel B Costa, Deepak Bararia, Daniel G Tenen, Hideo Watanabe, Susumu S Kobayashi
TIP60 is required for tumorigenesis in non-small cell lung cancer. Cancer science (2023)
Kei Oguchi, Hikari Araki, Shingo Tsuji, Masayuki Nakamura, Akihiro Miura, Kaoru Funabashi, Akiko Osada, Sakiho Tanaka, Takamasa Suzuki, Susumu S Kobayashi, Shinji Mizuarai
TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations. Cancer science (2022)
Yukie Kashima, Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S Kobayashi, David Plotnick, Hibiki Udagawa, Hiroki Izumi, Yuji Shibata, Kosuke Tanaka, Masanori Fujii, Akihiro Ohashi, Masahide Seki, Koichi Goto, Katsuya Tsuchihara, Yutaka Suzuki, Susumu S Kobayashi
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer. Cancer research 81 (18) (2021)
Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori, Kumiko Hayashi, Shogo Kumagai, Yuji Shibata, Takuma Hayashida, Kana Watanabe, Tatsuro Fukuhara, Takaya Ikeda, Kiyotaka Yoh, Terufumi Kato, Kazumi Nishino, Atsushi Nakamura, Ichiro Nakachi, Shoichi Kuyama, Naoki Furuya, Jun Sakakibara-Konishi, Isamu Okamoto, Kageaki Taima, Noriyuki Ebi, Haruko Daga, Akira Yamasaki, Masahiro Kodani, Hibiki Udagawa, Keisuke Kirita, Yoshitaka Zenke, Kaname Nosaki, Eri Sugiyama, Tetsuya Sakai, Tokiko Nakai, Genichiro Ishii, Seiji Niho, Atsushi Ohtsu, Susumu S Kobayashi, Koichi Goto
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. Nature 600 (7888) (2021)
Kota Ishioka, Hiroyuki Yasuda, Junko Hamamoto, Hideki Terai, Katsura Emoto, Tae-Jung Kim, Shigemichi Hirose, Takashi Kamatani, Sachiyo Mimaki, Daisuke Arai, Keiko Ohgino, Tetsuo Tani, Keita Masuzawa, Tadashi Manabe, Taro Shinozaki, Akifumi Mitsuishi, Toshiki Ebisudani, Takahiro Fukushima, Mari Ozaki, Shinnosuke Ikemura, Ichiro Kawada, Katsuhiko Naoki, Morio Nakamura, Takashi Ohtsuka, Hisao Asamura, Katsuya Tsuchihara, Yuichiro Hayashi, Ahmed E Hegab, Susumu S Kobayashi, Takashi Kohno, Hideo Watanabe, David M Ornitz, Tomoko Betsuyaku, Kenzo Soejima, Koichi Fukunaga
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer. Cancer research 81 (14) (2021)
Simone Ummarino, Clinton Hausman, Giulia Gaggi, Lucrezia Rinaldi, Mahmoud Adel Bassal, Yanzhou Zhang, Andy Joe Seelam, Ikei S Kobayashi, Marta Borchiellini, Alexander K Ebralidze, Barbara Ghinassi, Bon Q Trinh, Susumu S Kobayashi, Annalisa Di Ruscio
NAD Modulates DNA Methylation and Cell Differentiation. Cells 10 (11) (2021)
Hisashi Takei, Hirofumi Fukuda, Gilbert Pan, Hiroyuki Yamazaki, Tadahiko Matsumoto, Yasuhiro Kazuma, Masanori Fujii, Sohei Nakayama, Ikei S Kobayashi, Keisuke Shindo, Riu Yamashita, Kotaro Shirakawa, Akifumi Takaori-Kondo, Susumu S Kobayashi
Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator. International journal of hematology 112 (3) (2020)
Hibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, Rumi Fujioka, Yumi Hakozaki, Mikiko Shibuya, Naomi Abe, Toshiharu Komori, Tomonori Haruma, Miki Terasaka, Ryoto Fujita, Akihiro Hashimoto, Kaoru Funabashi, Hiroyuki Yasuda, Kazutaka Miyadera, Koichi Goto, Daniel B Costa, Susumu S Kobayashi
TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant EGFR Mutations. Molecular cancer research : MCR 17 (11) (2019)
Susan E Jorge, Antônio Roberto Lucena de Araujo, Hiroyuki Yasuda, Zofia Piotrowska, Geoffrey R Oxnard, Deepa Rangachari, Mark S Huberman, Lecia V Sequist, Susumu S Kobayashi, Daniel B Costa
EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
Hisashi Takei, Susumu S Kobayashi
Targeting transcription factors in acute myeloid leukemia. International journal of hematology 109 (1) (2018)
Radhakrishnan Sridhar, Hisashi Takei, Riyaz Syed, Ikei S Kobayashi, Liu Bee Hui, Ahmed Kamal, Daniel Geoffrey Tenen, Susumu S Kobayashi
Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα. Molecules (Basel, Switzerland) 23 (8) (2018)

Susumu S Kobayashi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Susumu S Kobayashi